Display Settings:

Format

Send to:

Choose Destination
    Cancer Lett. 2012 Apr 1;317(1):49-55. Epub 2011 Nov 13.

    Transplacental carcinogenesis with dibenzo[def,p]chrysene (DBC): Timing of maternal exposures determines target tissue response in offspring.

    Source

    Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR 97331, USA; The Linus Pauling Institute, Oregon State University, Corvallis, OR 97331, USA.

    Abstract

    Dibenzo[def,p]chrysene (DBC) is a transplacental carcinogen in mice (15mg/kg; gestation day (GD) 17). To mimic residual exposure throughout pregnancy, dams received four smaller doses of DBC (3.75mg/kg) on GD 5, 9, 13 and 17. This regimen alleviated the previously established carcinogenic responses in the thymus, lung, and liver. However, there was a marked increase in ovarian tumors (females) and hyperplastic testes (males). [(14)C]-DBC (GD 17) dosing revealed transplacental distribution to fetal tissues at 10-fold lower concentrations than in paired maternal tissue and residual [(14)C] 3weeks post-dose. This study highlights the importance of developmental stage in susceptibility to environmental carcinogens.

    Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

    PMID:
    22085489
    [PubMed - in process]
    PMCID:
    PMC3269513
    [Available on 2013/4/1]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk